Neuphoria Therapeutics (BNOXN) Q4 2022 Earnings Report
MX:BNOXN Q4 2022 EPS Results
- Actual EPS
- -MXN 241.64
- Consensus EPS
- -MXN 20,364.91
- Beat/Miss
- Beat by +MXN 20,123.26
- One Year Ago EPS
- -MXN 0.16
MX:BNOXN Q4 2022 Revenue Results
- Actual Revenue
- MXN 3.31M
- Expected Revenue
- MXN 5.06M
- Beat/Miss
- Missed by -MXN 1.75M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 08/25/2022
- Time
- Before Open
- Conference Call
- Thursday, August 25, 2022
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNOXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 29, 2025 | 2025 (Q4) | -36.26-45.92 | -509.96 | 91.00% (+464.04) | |
| Feb 20, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Aug 21, 2024 | 2024 (Q4) | -16.55-16.55 | -18.44 | 10.23% (+1.89) | |
| Feb 22, 2024 | 2024 (Q2) | ―-18.45 | -25.67 | 28.10% (+7.21) | |
| Aug 23, 2023 | 2023 (Q4) | -19.55- | -20.13 | ― | |
| Feb 23, 2023 | 2023 (Q2) | -139.15-308.08 | -106.85 | -188.32% (-201.22) | |
| Aug 25, 2022 | 2022 (Q4) | -20364.91-241.64 | -0.16 | -153677.78% (-241.48) | |
| Feb 22, 2022 | 2022 (Q2) | -214.67-106.85 | 0 | ― | |
| Aug 25, 2021 | 2021 (Q4) | 0.00-0.16 | 0 | ― | |
| Feb 26, 2021 | 2021 (Q2) | 0.000.00 | -19.42 | 100.00% (+19.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
